Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol. 2019;20(6):849–61. Article CAS PubMed Google Scholar Nivolumab plus Ipilimumab Achieves ...
Treatment with tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, and regorafenib is effective in controlling unresectable disease; however, drug resistance caused by secondary KIT or PDGFRA mutations eventually develops in 90% of cases. Adjuvant therapy with imatinib is commonly used to ...
MANTIS is to take the average value as MSI score after calculating the allele distribution difference value of each microsatellite site by comparing tumor and normal samples. MANTIS can detect more MS sites and maintain high accuracy. At present, MANTIS is widely used in the MSI detection of pan...
1 In this molecular era there is now a restructured classification of several CNS tumors. One aspect of the restructuring that Update on diagnostics In light of the advances detailed earlier, molecular testing has become essential for the optimal workup of CNS tumors.9 Application of molecular ...
Cancers 2023, 15, 3781 12 of 18 Molecule Bevacizumab Ramucirumab Aflibercept Axitinib Sorafenib Sunitinib Imatinib Lenvatinib Cabozantinib Pazopanib Regorafenib Table 1. Selected vascular endothelial growth factor-targeted therapies with associated half-life timing and recommended treatment termination time before...
Twitter Google Share on Facebook AcronymDefinition MCRCMetastatic Colorectal Cancer MCRCMarine Corps Recruiting Command(USMC) MCRCMalicious Code Research Center(Finjan Software) MCRCMarin Computer Resource Center(Novato, CA) MCRCMuslim Civil Rights Center(formerly Muslim Americans for Civil Rights and Le...